chemerin human elisa cat  (BioVendor Instruments)

Journal: Frontiers in Medicine

Article Title: Serum omentin and chemerin levels in patients with coronavirus disease 2019

doi: 10.3389/fmed.2026.1785101

Figure Lengend Snippet: Serum omentin (A) and chemerin (B) concentrations in COVID-19 patients and controls. Bars represent medians with interquartile ranges (IQR); dots indicate individual data points. Between-group comparisons (COVID-19 vs. controls) were performed using the Mann–Whitney U test; within-patient day 0 vs. day 7 comparisons were performed using the Wilcoxon signed-rank test. p -values for control vs. day 0, control vs. day 7, and day 0 vs. day 7 comparisons are shown in each panel.

Article Snippet: Serum concentrations of chemerin and omentin-1 were measured in duplicate using sandwich enzyme-linked immunosorbent assay (ELISA) kits (BioVendor, Brno, Czech Republic) (Chemerin Human ELISA, Cat. No. RD191136200R; Omentin-1 Human ELISA, Cat. No. RD191100200R) according to the manufacturer’s instructions.

Techniques: MANN-WHITNEY, Control

Journal: Biomedical Reports

Article Title: Increased serum chemerin level to predict early onset of aortic valve stenosis

doi: 10.3892/br.2017.1010

Figure Lengend Snippet: Sensitivity and specificity of the chemerin and FGF-21 in patients with aortic valve stenosis (including all severity degrees of stenosis).

Article Snippet: We obtained laboratory analyses for all the patients at the Biochemistry Laboratory of the Riga Stradins University, including chemerin and FGF-21 with the ELISA method, using human Chemerin ELISA (cat. no. EZHCMRN-57K) and human FGF-21 ELISA (cat. no. EZHFGF21-19K) kits, both produced by EMD Millipore (Billerica, MA, USA).

Techniques:

Journal: Biomedical Reports

Article Title: Increased serum chemerin level to predict early onset of aortic valve stenosis

doi: 10.3892/br.2017.1010

Figure Lengend Snippet: Sensitivity and specificity of chemerin and FGF-21 in the mild AoV stenosis group.

Article Snippet: We obtained laboratory analyses for all the patients at the Biochemistry Laboratory of the Riga Stradins University, including chemerin and FGF-21 with the ELISA method, using human Chemerin ELISA (cat. no. EZHCMRN-57K) and human FGF-21 ELISA (cat. no. EZHFGF21-19K) kits, both produced by EMD Millipore (Billerica, MA, USA).

Techniques:

Journal: Biomedical Reports

Article Title: Increased serum chemerin level to predict early onset of aortic valve stenosis

doi: 10.3892/br.2017.1010

Figure Lengend Snippet: Box and whisker plot of chemerin and FGF-21 in the control and AoV stenosis groups. The highest plasma chemerin level was found in mild AoV stenosis. The highest plasma FGF-21 level was found in severe AoV stenosis. FGF-21, fibroblast growth factor-21; AoV, aortic valve.

Article Snippet: We obtained laboratory analyses for all the patients at the Biochemistry Laboratory of the Riga Stradins University, including chemerin and FGF-21 with the ELISA method, using human Chemerin ELISA (cat. no. EZHCMRN-57K) and human FGF-21 ELISA (cat. no. EZHFGF21-19K) kits, both produced by EMD Millipore (Billerica, MA, USA).

Techniques: Whisker Assay, Control, Clinical Proteomics

Journal: Biomedical Reports

Article Title: Increased serum chemerin level to predict early onset of aortic valve stenosis

doi: 10.3892/br.2017.1010

Figure Lengend Snippet: ROC analysis of chemerin and FGF-21 as diagnostic markers of AoV stenosis in the control group vs. all stenosis groups. Chemerin: AUC=0.76 and precision category, fair, a moderate diagnostic biomarker for AoV stenosis; FGF-21: AUC=0.67 and precision category, poor, weak, biomarker for AoV stenosis. AUC, area under the curve; ROC, receiver-operating characteristic; FGF-21, fibroblast growth factor-21.

Article Snippet: We obtained laboratory analyses for all the patients at the Biochemistry Laboratory of the Riga Stradins University, including chemerin and FGF-21 with the ELISA method, using human Chemerin ELISA (cat. no. EZHCMRN-57K) and human FGF-21 ELISA (cat. no. EZHFGF21-19K) kits, both produced by EMD Millipore (Billerica, MA, USA).

Techniques: Diagnostic Assay, Control, Biomarker Discovery

Journal: Biomedical Reports

Article Title: Increased serum chemerin level to predict early onset of aortic valve stenosis

doi: 10.3892/br.2017.1010

Figure Lengend Snippet: ROC analysis of chemerin and FGF-21 as diagnostic markers of the AoV stenosis – control group vs. the mild AoV stenosis group. Chemerin: AUC=0.82 and precision category, good, a good diagnostic biomarker for AoV stenosis; FGF-21: AUC=0.66 and precision category, poor, weak, biomarker for AoV stenosis. AUC, area under the curve; ROC, receiver-operating characteristic; FGF-21, fibroblast growth factor-21

Article Snippet: We obtained laboratory analyses for all the patients at the Biochemistry Laboratory of the Riga Stradins University, including chemerin and FGF-21 with the ELISA method, using human Chemerin ELISA (cat. no. EZHCMRN-57K) and human FGF-21 ELISA (cat. no. EZHFGF21-19K) kits, both produced by EMD Millipore (Billerica, MA, USA).

Techniques: Diagnostic Assay, Control, Biomarker Discovery